FDA fi­nal­izes guid­ance on place­bos and blind­ing for can­cer tri­als

The FDA on Wednes­day fi­nal­ized guid­ance rec­om­mend­ing that drug­mak­ers on­ly use place­bos in can­cer clin­i­cal tri­als in se­lect cir­cum­stances due to eth­i­cal con­cerns that would …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER